SCHEMBL23572575

SCHEMBL23572575

COc1cc2c(O)cc3c(c2cc1O)-c1ccc(-c2ccccc2)cc1C3(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CHEK1 O14757 2/20 0.37
CDK4 P11802 2/20 0.37
CCND1 P24385 2/20 0.37
FYN P06241 1/20 0.37
FGFR1 P11362 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCND3 P30281 1/20 0.37
KDR P35968 1/20 0.37
EGFR P00533 1/20 0.36
PDK2 Q15119 3/20 0.36
ABCC1 P33527 4/20 0.36
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30104203 1.00 ALDH1A1 (0.38) ALDH1A1KDM4ETP53CYP2D6CYP2C19
SCHEMBL1010811 0.95 EGFR (0.38) CHEK1CDK4CCND1FYNFGFR1
SCHEMBL164197 0.95 EGFR (0.38) CHEK1CDK4CCND1FYNFGFR1
SCHEMBL2200232 0.85 PDK2 (0.41) ALDH1A1KDM4ETP53CYP2D6CYP2C19
SCHEMBL30104202 0.85 PDK2 (0.41) ALDH1A1KDM4ETP53CYP2D6CYP2C19
SCHEMBL1012466 0.85 FYN (0.37) ALDH1A1KDM4ECYP2D6CYP2C19FYN
SCHEMBL30125488 0.85 PDK2 (0.47) ALDH1A1KDM4ECYP2D6CYP2C19HSD17B10
SCHEMBL8513816 0.85 PDK2 (0.47) ALDH1A1KDM4ECYP2D6CYP2C19HSD17B10
SCHEMBL1816275 0.85 KDM4E (0.36) ALDH1A1KDM4EHSD17B10MEN1POLB
SCHEMBL1010936 0.84 RARA (0.48) EGFRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518751-B2 Photochromic indeno-fused naphthopyran compounds with reduced temperature dependence TRANSITIONS OPTICAL, LTD. (IE) 2022-12-06 US disclosed
EP-3802508-B1 PHOTOCHROMIC INDENO-FUSED NAPHTHOPYRAN COMPOUNDS WITH REDUCED TEMPERATURE DEPENDENCE TRANSITIONS OPTICAL LTD (IE) 2022-10-19 EP disclosed
US-20210198226-A1 Photochromic Indeno-Fused Naphthopyran Compounds With Reduced Temperature Dependence TRANSITIONS OPTICAL, LTD. (IE) 2021-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198226-A1 Photochromic Indeno-Fused Naphthopyran Compounds With Reduced Temperature Dependence NR2E3, NR0B2, NR2C2 ALDH1A1 1149/4885KDM4E 4170/4885TP53 2427/4885
US-11518751-B2 Photochromic indeno-fused naphthopyran compounds with reduced temperature dependence NR2E3, NR0B2, NR2C2 ALDH1A1 1149/4885KDM4E 4170/4885TP53 2427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.